Our Services
Medical Information
Helpful Resources
Published on: 5/5/2026
Creatine is a natural compound that enhances brain energy metabolism by boosting phosphocreatine and ATP levels, and it has shown promising neuroprotective effects in preclinical models and early trials of rare neurodegenerative disorders such as Huntington’s disease.
There are several factors to consider—including optimal dosing, safety monitoring (especially kidney function), and the current mixed clinical evidence—so see below for a detailed discussion that can inform your next steps.
Neuroprotection refers to strategies designed to preserve the structure and function of nerve cells (neurons) in the face of injury or disease. In recent years, creatine—a compound best known for its use in sports nutrition—has gained attention for its potential to support brain health, especially in rare neurodegenerative disorders such as Huntington's disease.
Neurons are energy-hungry cells. They rely on a steady supply of ATP to:
When energy production falters, neurons become vulnerable to damage and death—a hallmark of Huntington's disease and other rare brain disorders.
Huntington's disease is a hereditary neurodegenerative condition characterized by:
It results from a genetic mutation that causes toxic fragments of the huntingtin protein to accumulate in neurons, disrupting mitochondrial function (the cell's "power plants") and leading to energy deficits.
Before considering creatine supplementation, discuss it with your doctor or neurologist. Typical approaches include:
Common side effects (usually mild):
Creatine is generally well tolerated, even at higher doses, but people with kidney impairment should use caution and seek medical guidance.
Research into creatine's neuroprotective role extends to several other conditions:
Although encouraging in preclinical studies, clinical data are still limited. Large, well-designed trials are needed to determine which conditions and patient subgroups might truly benefit.
If you or a loved one experience any new or worsening neurological symptoms—such as uncontrollable movements, speech difficulties, balance problems or rapid cognitive changes—prompt evaluation is crucial. To help organize your symptoms and prepare for your doctor's visit, try using a Medically approved LLM Symptom Checker Chat Bot that can provide personalized insights based on your specific concerns.
Creatine holds promise as a neuroprotective supplement thanks to its established role in cellular energy metabolism. While large trials in Huntington's disease have yet to demonstrate clear clinical benefit, creatine remains safe for most people and may offer modest support to brain energy homeostasis. As research continues, creatine may find a defined place in multi-modal treatment plans for Huntington's disease and other rare neurodegenerative disorders.
Always speak to a doctor before starting any supplement—especially if you have kidney issues, are on multiple medications or are managing a serious neurological condition. Professional guidance ensures that any intervention supports your overall health and treatment goals.
(References)
* Nabuurs CI, van der Knaap MS, de Sain-van der Velden MG, Bunge M, Wokke BH, de Koning TJ. Creatine transport and metabolism in the brain: From neurodevelopment to neurodegeneration. Biochem J. 2013 Aug 1;453(3):323-39. doi: 10.1042/BJ20130097. PMID: 23742468.
* Salomons GS, Van der Knaap MS, Bakker HD. Cerebral Creatine Deficiency Syndromes: Diagnosis and Management. Mol Genet Metab. 2011 Dec;104(4):460-7. doi: 10.1016/j.ymgme.2011.08.001. PMID: 21855427.
* Mercimek-Andrews S, Salomons GS, Cecil KM, Bok LA, De Sain-van der Velden MG, Marchessault S, van der Knaap MS, Blaser S, Knoflach F, Stöckler S, De Koning TJ. Clinical, biochemical, and molecular aspects of creatine transporter deficiency: a review of the literature. Mol Genet Metab. 2010 Jun;100(2):117-21. doi: 10.1016/j.ymgme.2010.02.012. PMID: 20303649.
* Schulze A, Salomons GS, Heerschap A, van der Knaap MS. Creatine and Cyclocreatine Therapy for Creatine Deficiency Syndrome. J Inherit Metab Dis. 2006;29(2-3):362-8. doi: 10.1007/s10545-006-0361-9. PMID: 16763907.
* Wallimann T, Tokarska-Schlattner M, Schlattner U. Creatine supplementation in brain energy metabolism and neuroprotection: a mini-review. FEBS Lett. 2011 May 17;585(12):1707-13. doi: 10.1016/j.febslet.2011.03.024. PMID: 21545814.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.